Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nektar Therapeutics (NQ: NKTR )

23.74 USD UNCHANGED
Streaming Delayed Price Updated: 7:00 AM EST, Mar 3, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 23.74
Bid (Size) 23.66 (1)
Ask (Size) 24.95 (1)
Prev. Close 23.74
Today's Range 23.74 - 23.74
52wk Range 13.63 - 26.75
Shares Outstanding 171,402,476
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Nektar Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results
Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2020. 
From PR Newswire
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2020 on Thursday, February 25, 2021, After Close of U.S.-Based Financial Markets
Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2020, on Thursday, February 25, 2021, after the close of U.S.-based financial... 
From PR Newswire

Performance

YTD
+34.43%
+34.43%
1 Month
+14.74%
+14.74%
3 Month
+44.14%
+44.14%
6 Month
+23.97%
+23.97%
1 Year
+18.11%
+18.11%

More News

Read More
Increasing R&D Studies to Develop Cancer Vaccines Attributed to Spike in Number of Cancer Patients
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Increasing R&D Studies to Develop Cancer Vaccines Attributed to Spike in Number of Cancer Patients
From PR Newswire
Nektar Announces Agreement for Phase 2/3 Study of IL-2 Pathway Agonist, Bempegaldesleukin, in Combination with Merck's KEYTRUDA® (pembrolizumab) in Patients with Squamous Cell Carcinoma of the Head an
From PR Newswire
Nektar Announces Collaboration with SFJ Pharmaceuticals® for Bempegaldesleukin in Head and Neck Cancer
From PR Newswire
Nektar Therapeutics: Q4 Earnings Insights
Tags BZI/Recaps Benzinga Earnings
From Benzinga
Nektar Therapeutics (NKTR) Q4 2020 Earnings Call Transcript
Tags Market News NKTR
From Motley Fool
Thinking about trading options or stock in Nektar Therapeutics, Sleep Number, General Electric, Twilio, or Spirit Airlines?
From PR Newswire
Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer
Tags Biotech News General
From Benzinga
Thinking about trading options or stock in Vir Biotechnology, Verizon, Nektar Therapeutics, Chevron, or Estee Lauder?
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.